Functional Impairment of Patients Undergoing Surgical Correction for Charcot Foot Arthropathy

• Published in: Foot & ankle international Vol. 38; no. 7; pp. 705 - 709
• Main Authors: Kroin, Ellen, Schiff, Adam, Pinzur, Michael S., Davis, Elissa S., Chaharbakhshi, Edwin, DiSilvio, Frank A.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01-07-2017
• Subjects: Arthropathy, Neurogenic - surgery; Diabetic Foot - physiopathology; Diabetic Foot - surgery; Foot; Humans; Musculoskeletal Diseases - physiopathology; Musculoskeletal Diseases - surgery; Orthopedics; Prospective Studies; Quality of Life; Surveys and Questionnaires; outcomes; Charcot foot; diabetic foot
• ISSN: 1071-1007; 1944-7876
• DOI: 10.1177/1071100717701233

Background:
Investigations using the Medical Outcomes Study Short Form 36 Healthy Survey (SF-36) and the American Orthopaedic Foot & Ankle Society Diabetic Foot Questionnaire (AOFAS-DFQ) have demonstrated a poor quality of life in patients with Charcot foot arthropathy. The Short Musculoskeletal Function Assessment (SMFA) questionnaire has been widely used in patients with a broad range of musculoskeletal disorders.
Methods:
Twenty-five consecutive patients undergoing operative correction for diabetes-related Charcot foot arthropathy of the midfoot completed the SMFA prior to undergoing surgery. There were 16 males and 9 females. The average body mass index (BMI) was 37.4 (range 25.8-50.2), and the average hemoglobin A1c was 7.5 (range 5.3-10.1) prior to surgery.
Results:
All 25 patients exhibited significant impairment in all 6 domains of the SMFA (P < .0001) as compared to the normative data. There was a high correlation between each of the 6 domains of the SMFA, even after correcting for BMI.
Conclusion:
Charcot foot severely impaired the quality of life in patients beyond the impact of morbid obesity. This impairment equally impacted all of the functional and emotional domains measured with the SMFA as compared with population norms. This investigation provides a benchmark for measuring the impact of operative correction of the deformity. In addition, the SMFA appears to be a valid tool for measuring impairment in this complex patient population.
Level of Evidence:
Level II, prospective comparative investigation